Amarin Corp Plc (AMRN)

[Pharmacydude]

Cardio
Dr Reddy:
“Our Generic Formulations business addresses this urgent need by offering more than 200 high-quality generic versions of expensive innovator medicines—at a fraction of the cost—in over 80 countries around the world.”

They are trying to get approved an exact generic copy of V that will eliminate 95% of V’s US market.

If Amarin loses on either of the 2 claims then they lose the entire US market for V.